Symposium 1 The Impact of social media in Liver Disease Research and Education – Is it time to embrace this more widely?

Wednesday, April 26 | 8:30 – 10:30

Moderators: Ahmed Elsharkawy (UK)

  • What do I gain from my involvement in social media – the viewpoint of a senior academic
    (8:30 – 8:50)
    AASLD: Juan Pablo Arab, University of Wester Ontario (Canada)
  • Medical Education Opportunities in social media – Tweetorials, journal clubs and more
    (8:50 – 9:10)
    AASLD: Elliot B. Tapper, University of Michigan Medical Center
  • An Editor’s View on the role of social media in the dissemination of research findings
    (9:10 – 9:30)
    EASL: 
  • Medical social media and the ‘Echo Chamber’ – the good, the bad and the ugly
    (9:30 – 9:50)
    EASL: 
  • Debate: HCPs have a moral obligation to be involved in social media to counteract disinformation
    (9:50 – 10:05)
    For: Philipp Schwabl, Medical University of Vienna (Austria)
    Against: Ahmed Elsharkawy (UK)
  • Panel Discussion
    (10:05 – 10:20)

Symposium 2 Disparities in Liver Cancer

Wednesday, April 26 | 14:00 – 16:00 

Moderators: AASLD – Juan Pablo Arab, University of Western Ontario & EASL – Jean Charles Nault, Avicenne Hospital, APHP

  • PART 1 –  Introductions
    (14:00 – 14:05)
  • Disparities in implementation of screening guidelines
    (14:05 – 14:25)
    EASL: Manon Allaire, Pitié Salpetrière Hospital (France)
  • Disparities and treatment outcomes
    (14:25 – 14:45)
    AASLD: Fasiha Kanwal, Michael E. DeBakey VA Medical Center (USA)
  • Q&A / Joint Panel EASL & AASLD
    (14:45 – 15:05)
  • PART 2 – HCV Screening in underserved cohorts at high risk for HCC 
    (15:05 – 15:25)
    AASLD: Norah Terrault, University of Southern California (USA)
  • Impact of social determinants of health on HCC outcomes
    (15:25 – 15:45)
    EASL: Charlotte Costentin
  • Q&A / Joint Panel AASLD & EASL
    (15:45 – 16:00)

SIGN ME UP FOR UPDATES